Status:
COMPLETED
The Extended Gestational Age Medical Abortion Study
Lead Sponsor:
Gynuity Health Projects
Conditions:
Medical Abortion
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- intrauterine pregnancy of greater than 56 days and less than 71 days
- eligible for medical abortion according to study doctor assessment
- willing and able to sign consent forms
- speak English or Spanish (in US sites); speak the local language(s) (in international sites)
- agree to comply with the study procedures and visit schedule
Exclusion
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT00997347
Start Date
July 1 2009
End Date
February 1 2012
Last Update
July 2 2012
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Presidential Women's Center
West Palm Beach, Florida, United States, 33407
2
Family Planning Associates Medical Group
Chicago, Illinois, United States, 60630
3
Planned Parenthood League of Massachusetts
Boston, Massachusetts, United States, 02215
4
Planned Parenthood, Minnesota, North Dakota, South Dakota
Saint Paul, Minnesota, United States, 55116